Defining the clinical course of multiple sclerosis

  title={Defining the clinical course of multiple sclerosis},
  author={Fred D Lublin and Stephen C. Reingold},
  pages={907 - 911}
Standardization of terminology used to describe the pattern and course of MS is essential for mutual understanding between clinicians and investigators.It is particularly important in design of, and recruitment for, clinical trials statistically powered for expected outcomes for given patient populations with narrowly defined entry criteria. For agents that prove safe and effective for MS, knowledge of the patient populations in definitive clinical trials assists clinicians in determining who… 

Figures from this paper

Defining the clinical course of multiple sclerosis
Refined descriptors that include consideration of disease activity (based on clinical relapse rate and imaging findings) and disease progression are proposed and strategies for future research to better define phenotypes are outlined.
The 2013 clinical course descriptors for multiple sclerosis
A clarification of the concepts underlying the clinical course descriptions of multiple sclerosis is provided and the critical importance of time framing the disease course modifiers activity and progression is highlighted.
Issues and Practices in Multiple Sclerosis
This review summarizes the main points of this roundtable discussion of experts in the field of multiple sclerosis and is intended to serve as a reference for neurologists involved in the care of patients with MS.
Clinical Course of Multiple Sclerosis.
There is still a lack of imaging and biological markers that would distinguish MS phenotypes and prognosticate the disease course on an individual patient's level, creating a pressing need for large collaborative research efforts in this field.
The clinical course of multiple sclerosis.
Active and progressive
A new consensus framework for MS classification is proposed and a new schema supplants the one proposed by Lublin and Reingold in 1996 depicting 4 courses of MS that has been widely embraced in research and in clinical practice.
Diagnosis of multiple sclerosis.
Key issues in the diagnosis and treatment of multiple sclerosis
This review provides a concise, up-to-date overview of key issues relating to MS and its management and discusses the use of MRI as a surrogate measure in MS treatment trials, with commentaries on the specific MRI-oriented publications related to the disease-modifying therapies.
Clinical outcome measures in multiple sclerosis.
  • B. Uitdehaag
  • Medicine, Psychology
    Handbook of clinical neurology
  • 2014


Severe nonfluency in aphasia. Role of the medial subcallosal fasciculus and other white matter pathways in recovery of spontaneous speech.
It is suggested that one explanation for the more severe limitation in spontaneous speech in the first group is the extensive white matter lesion in these two subcortical pathways had interrupted a large number of connections for initiation and preparation of speech movements and limbic aspects of speech.
Duchenne muscular dystrophy
It seems likely that, once the entire gene (cDNA) is available for screening, most DMD boys will show deletions, and the effort involved in screening all affected boys for deletions is considerably less.
Autosomal dominant cerebellar phenotypes
The dominantly inherited ataxias comprise a series of clinical phenotypes that include ataxia, dysarthria, dysmetria, and intention tremor resulting from the involvement of the cerebellum and its
The evolution of multiple sclerosis epidemiology